“Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients with Type 2 Diabetes; A True Game Changer”, IJBR, vol. 3, no. 2, pp. 193–198, Feb. 2025, doi: 10.70749/ijbr.v3i2.663.